Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dupilumab in Severe Chronic Hand Eczema With Inadequate Response or Intolerance to Alitretinoin

NCT04512339 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04512339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04512339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dupilumab in Severe Chronic Hand Eczema With Inadequate Response or Intolerance to Alitretinoin
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hand eczema